期刊文献+

联合应用塞莱西布和CpG-ODN对树突状细胞功能的影响 被引量:1

Contribution on function of dendritic cell by combining celecoxib and CpG-ODN
下载PDF
导出
摘要 目的观察联合应用COX-2抑制剂塞莱西布和免疫佐剂CpG-ODN对树突状细胞(DC)功能的影响,研究其生物效应。方法分离和培养人脐血来源树突状细胞,按分组进行预处理和诱导成熟,光镜及电镜观察DC形态,流式细胞仪检测表面标志CD1a、CD83、HLA-DR的表达情况以及进行细胞因子IL-10I、L-12水平测定(ELISA)。结果按预定方法诱导成熟的DC,其形态学无明显异常,流式细胞检测证实了其正常成熟并具有生物活性,细胞因子的测定表明实验组IL-12含量明显增高,IL-10含量明显降低,Th1/Th2应答平衡出现明显的免疫漂移现象。结论联合应用COX-2抑制剂和CpG-ODN可明显增强DC的生物学活性,为建立基于DC的肿瘤生物治疗打下了良好的基础。 Objective To observe the contribution on function of dendritic cell by using COX-2 Inhibitor, eelecoxib, and CpG- ODN,and study the biological effect. Methods DC from humen cord blood was separated,cultivated,preconditioned and induced to maturity. The appearance of DC was observed by light microscope and electron microscope. Expression of surface markers including CD1a,CD83 and HLA DR were detected by flowcytometry. Then the level of cytokine IL10 and IL-12 were detected by ELISA. Results The appearance of DC was normal. It was confirmed that DC has more powerful bioactivity and it could lead to immuno logical drift obviously. Conclusion The biological effect of DC has been enhanced by combining celecoxib and CpG-ODN. Better prospect should be anticipated in tumor theropy based DC.
出处 《重庆医学》 CAS CSCD 2008年第20期2299-2301,共3页 Chongqing medicine
基金 重庆市自然科学基金资助项目(13165)
关键词 树突状细胞 COX-2抑制剂 佐剂 免疫 dendritic cell COX-2 inhibitor adjuvants immunologic
  • 相关文献

参考文献8

  • 1Fazekas De St Groth B,Smith AI.,Bosco J,et al. Experimental models linking dendritic cell lineage, phenotype and function[J]. Immunol Cell Biol,2002.80(5): 469.
  • 2Gabrilovich DI, Ciemik IF, Carbone DP. Dendritic cells in antitumor immune response. I. Defective antigen presentation in tumorbearing hosts[J]. Cell Immunol, 1996, 170 (1):101.
  • 3Mohammed SI, Knapp DW, Bostwick DG, et al. Expression of cyclooxygenase-2(COX 2) in human invasive tran sitional cell carcinoma (TCC) of the urinary bladder[J]. Cancer Res,1999,59(22) :5647.
  • 4卓文利,靳风烁,李黔生,江军,聂志林.膀胱移行细胞癌中树突状细胞浸润及其表面分子表达变化的临床意义[J].医学临床研究,2004,21(11):1235-1237. 被引量:5
  • 5Actins H,Davis BR, Kirby JA, et al. Polarisation of a Thelper cell immune response by activation of dendritic cells with CpG containing oligonucleotides: a potentiao therapeutic regime: for bladder cancer immunotherapy [J]. Br J Cancer,2003,89(12) :2312.
  • 6Weiner GJ, Liu HM, Wooldrige JE, et al. Immunostimulatory oligodeoxynucletotides containing the CpG motif are effective as adjuvants in tumor antigen immunization[J]. Proc Natl Acad Sci USA,1997,94(8):10833.
  • 7聂志林,靳风烁,王洛夫,梁培禾,叶锦.CpG-ODN预防膀胱肿瘤复发的可行性研究[J].第三军医大学学报,2006,28(10):1054-1056. 被引量:2
  • 8Choi YK, Kim YJ,Park HS, et al. Suppression of glomer ulosclerosis by adenovirus mediated IL-10 expression in the kidney[J]. Gene Ther,2003,10(7) :559.

二级参考文献21

  • 1TOKUNAGA T,YAMAMOTO H,SHIMADA S,et al.Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG.Ⅰ.Isolation,physicochemical characterization,and antitumor activity[J].J Natl Cancer Inst,1984,72(4):955 -962.
  • 2HARTMANN G,KRIEG A M.Mechanism and function of a newly identified CpG DNA motif in human primary B cells[J].J Immomol,2000,164(2):944 -953.
  • 3ATKINS H,DAVIES B R,KIRBY J A,et al.Polarisation of a Thelper cell immune response by activation of dendritic cells with CpGcontaining oligonucleotides:a potential therapeutic regime for bladder cancer immunotherapy[J].Br J Cancer,2003,89(12):2312-2319.
  • 4ESUVARANATHAN K,ALEXANDROFF A B,MCINTYRE M,et al.Interleukin-6 production by bladder tumors is upregulated by BCG in immunotherapy[J].J Urol,1995,154(2 Pt 1):572 -575.
  • 5DE-REIJKE T M,DE-BOER E C,KURTH K H,et al.Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer:processing,stability and prognostic value[J].J Urol,1996,155(2):477 -482.
  • 6WEINER G J,LIU H M,WOOLDRIDGE J E,et al.Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization[J].Proc Natl Acad Sci U S A,1997,94(20):10833 -10837.
  • 7HOSHINO K,KAISHO T,IWABE T,et al.Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation[J].Int Irnmunol,2002,14(10):1225 -1231.
  • 8BRIGHTBILL H D,MODLIN R L.Toll-like receptors:molecular mechanisms of the mammalian immune response[J].Immunology,2000,101(1):1-10.
  • 9VOLLMER J,WEERATNA R,PAYETTE P,et al.Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities[J].Eur J Immunol,2004,34(1):251 -262.
  • 10KAWARADA Y,GANSS R,GARBI N,et al.NK-and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides[J].J Immunol,2001,167(9):5247 -5253.

共引文献4

同被引文献8

  • 1卓文利,靳风烁.环氧化酶-2与膀胱肿瘤免疫逃逸[J].实用癌症杂志,2004,19(6):660-662. 被引量:1
  • 2卓文利,靳风烁,李黔生,江军,聂志林.膀胱移行细胞癌中树突状细胞浸润及其表面分子表达变化的临床意义[J].医学临床研究,2004,21(11):1235-1237. 被引量:5
  • 3Banchereau J,Briere F,Caux C, etal.Immunobiology of dendritic cells. Annu-Rev Immunol . 2000
  • 4Fazekas De St Groth B,L Smith A,Bosco J, et al.Experimental models linking dendritic cell lineage, phenotype and function. Immunology and Cell Biology . 2002
  • 5Teleshova N,Kenney J,Robbiani M.Dendritic cells and HIV infection: activating dendritic cells to boost immunity. Advances in Dental Research . 2006
  • 6Trumpfheller C,Finke JS,Lopez CB,Moran TM,Moltedo B,Soares H, et al.Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. The Journal of Experimental Medicine . 2006
  • 7Saint F,Patard JJ,Maille P,et al.T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer. Journal d Urologie . 2001
  • 8Choi YK,Kim YJ,Park HS,et al.Suppression of glomerulosclero-sis by adenovirus-mediated IL-10 expression in the kidney. Gene Therapy . 2003

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部